ClarityOfPurpose Posted - 6 hours ago

$CNSP They want to reprice millions of Oct 2023 warrants from $1.28 to $0.30. Now exactly why is that? Is it to reward their hedge fund buddies who were probably already making money anyway by shorting the stock down to $.30 in the first place? CNSP is not doing any repricing for common stockholders like me and you, who bought at market pricing during that time.

dael_000 Posted - 11 hours ago

$CNSP loaded up 13,500 more shares, LSX World Congress Presentation is on Monday morning.

CandleGuy Posted - 18 hours ago

$CNSP just bought more.

NetworkNewsWire Posted - 21 hours ago

Researchers Seek to Develop Genetically Engineered Brain Cancer Treatment $CNSP https://ibn.fm/O3QsZ #biomedstocks #cancer

Samiam69 Posted - 23 hours ago

$cnsp 🤔💸

donatflorida Posted - 1 day ago

$CNSP

donatflorida Posted - 1 day ago

$CNSP

Herbgator Posted - 1 day ago

$CNSP one thing unique that I hadn’t focused on before John’s lunch break conference Tuesday that he pointed out was previous studies of L included other brain cancers mixed in with GBM. Therefore the OS for the L-arm in the current trial should be shorter than previous studies as a pure play vs B. I would, therefore, expect 100% of the L participants to be ‘events’ very soon (unfortunately) leaving B to stand alone. Statistically, I could already make such a case of benefit or not with high confidence but with the entire study group coming in shortly due to enrollment skew, they will probably wait longer to be even more confident one way or another. I would only seek incremental funding for a few months at a time because the minute the committee calls it and unblinds due to performance or terminates it as a failure, capital will be easier to raise or won’t be needed at all. In my opinion!

dael_000 Posted - 1 day ago

$CNSP After attending the April 9 presentation, I decided to acquire an additional 10,500 shares. I was impressed by the speaker’s confident demeanor, especially when discussing berbucin. While the stock’s decline may be attributed to financial constraints, the forthcoming infusion of funds, though I can’t recall the precise date, is a pivotal development. This injection of capital is crucial for bolstering investor confidence and, ultimately, attracting further investment. Moreover, the fact that they have tangible proof of the drug’s efficacy is highly impressive.

donatflorida Posted - 1 day ago

$CNSP A really good case study is Trillium Therapeutics. If any you folks know the company, CEO Jan Skvarka managed to boost the share price and increase cash at the same time. They announced an equity raise along with a partner (Pfizer) at the exact same time. The partner came in with a financial injection of $25 million, got a seat as a director and first crack at more equity. The partnership was set at a valuation higher than its share price and the equity raise was set at the around the same price. This gave credibility to the company and the underwriters had more weight behind the higher valuation. Pfizer ended up buying the company outright. I hope John knows this story as I think it would be a good example of how to shift the market valuation upward. https://www.fiercebiotech.com/biotech/pfizer-and-trillium-how-a-25m-investment-led-to-a-2-3b-buyout

Woodman7 Posted - 1 day ago

$CNSP - Watching the recent video, you walk away with the fact that there is a MAJOR disconnect between what the company is saying and the market’s perception of the opportunity. A $2m market cap?!? A company that has exclusive rights to a drug that is ~6-8 months from concluding a thus-far positive “potentially pivotal study” on GBM - a $9b/yr TAM. Doesn’t make sense. The risk/reward equation is broken.

GaryCaresInvestments Posted - 2 days ago

$CNSP presentation from 09 APR is now available for replay. More confidence. Not IF approval, WHEN approval is the underlying theme. Worth a watch, only 27 minutes long. Questions at the end are different than what was asked earlier this week. John answers all head on and very well.

donatflorida Posted - 2 days ago

$CNSP my only concern (other than not getting FDA approval) is the share price along with its outstanding share count. If management would require additional funds prior to getting advised by the FDA, it places them in a precarious position in terms of bargaining power for the money.

Woodman7 Posted - 3 days ago

$CNSP - others have referenced this video. Very well worth watching. I’ve been in the stock for about a year now and obviously down a pretty significant amount, but find this to be very encouraging and wish that this company and stock could get a little more air play as I believe it is a real opportunity here. Praying that he is right and Berubicin will achieve positive results for current and future GBM patients.

Woodman7 Posted - 3 days ago

@TheGreatBh - the new board member and the Vants have all kinds of connections in DC. It just May happen. $CNSP

Balespur Posted - 3 days ago

$CNSP John would not have mentioned a possible NIH grant if he did not think it was probable. Would be a huge boost to the stock.

donatflorida Posted - 3 days ago

$CNSP Call me a fool; I've added today. In my assessment of today's presentation, and all available data, I believe the odds are in favour of positive FDA news by this time next year. I agree with John that the FDA's bar for approval regarding GBM is low and any amelioration to the current treatment is a green light. Given the reasons were many to stop the trial in January, the odds substantially increased for a positive outcome.

TheGreatBh Posted - 3 days ago

$CNSP was also happy with the presentation. hes a smooth talker i guess thats why he still has a job! he mentioned applying for an nih grant. anyone with experience with this stuff know if that is a viable/realistic funding option?

Samiam69 Posted - 3 days ago

$CNSP did another R/S come up

Kocatka Posted - 3 days ago

$CNSP Very good Q & A segment except for the question about the small sample size for a ph2 at the end WTF. My question was combined with that one which asked right after: if Lomustine arm was completed early say in eight months would trial reach necessary threshold and top line data be released early ahead of company projections. Very informative otherwise and definitely a must watch for those investing with the intent on seeing this through to the top line results.

donatflorida Posted - 3 days ago

$CNSP good presentation. John did indicate a few things that increased my confidence such as the possible reasons for the FDA's clinical trial decision in January.

GaryCaresInvestments Posted - 3 days ago

$CNSP Great presentation, went over an hour today. The answering of a multitude of questions was 👍🏼

Stock_Titan Posted - 3 days ago

$CNSP CNS Pharmaceuticals to Present at the LSX World Congress 2024 https://www.stocktitan.net/news/CNSP/cns-pharmaceuticals-to-present-at-the-lsx-world-congress-xlr498h11i6z.html

FMFBULL0321USMC Posted - 4 days ago

$CNSP Price action. Fifty cents. Let’s go.

NetworkNewsWire Posted - 4 days ago

BioMedNewsBreaks – $CNSP Spotlighted in Upcoming Virtual Investor Lunch Break Event https://ibn.fm/t3aYU

NetworkNewsWire Posted - 4 days ago

BioMedNewsBreaks – $CNSP Spotlighted in Upcoming Virtual Investor Lunch Break Event https://ibn.fm/t3aYU

Samiam69 Posted - 4 days ago

$CNSP friends and family

Stock_Titan Posted - 4 days ago

$CNSP CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity https://www.stocktitan.net/news/CNSP/cns-pharmaceuticals-to-participate-in-the-virtual-investor-lunch-qg2oy9n2a8lj.html

ClarityOfPurpose Posted - 4 days ago

$CNSP Just remember that this is the same Management that claims to have used ‘best efforts’ to propose a cash raise on Jan 10 at the ‘then-market price’ of $1.15 plus one warrant. Instead, with the positive Interim Report and enrollment news, they wound up doing the actual deal three weeks later at just $0.30 which included two bundled warrants. Who had access to that super-friendly deal? Why, officers and directors of course, and ‘certain investors’ such as their hedge fund buddies, Armistice Capital. Interpret that sequence of events however you wish.

GaryCaresInvestments Posted - 5 days ago

$CNSP Been awhile since we had a solid run for no reason at all. Has happened a couple times before. 🤷🏼‍♂️🙏🏼🐝🚀🪐